Medicalsystem Biotechnology Co.Ltd(300439)
Securities code: 300439 securities abbreviation: Medicalsystem Biotechnology Co.Ltd(300439) Announcement No.: 2022-005 Medicalsystem Biotechnology Co.Ltd(300439)
Announcement on three wholly-owned subsidiaries obtaining high-tech enterprise certificates
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Basic information
Three wholly-owned subsidiaries of Medicalsystem Biotechnology Co.Ltd(300439) (hereinafter referred to as “the company”), Shenzhen Meikang Shengde Medical Laboratory (hereinafter referred to as “Shenzhen Shengde medical laboratory”), Ningbo Meikang Shengde medical laboratory Co., Ltd. (hereinafter referred to as “Ningbo Shengde medical laboratory”) Ningbo Meikang Shengde Biotechnology Co., Ltd. (hereinafter referred to as “Shengde biotechnology”) has obtained the certificate of high tech enterprise recently. The details are as follows:
Name of subsidiary issuing unit certificate No. issuing time validity period first recognition time
Shenzhen Science and technology innovation
Shenzhen Shengde Medical Committee, Shenzhen finance
Gr202144204992 December 23, 2021 three years 2021
The Political Bureau of the public prosecutor’s office and the General Administration of State Taxation
Shenzhen Taxation Bureau
Ningbo Science and technology
Ningbo Shengde medical bureau, Ningbo Municipal Finance Bureau
Gr202133100796 December 10, 2021 three years 2015
Inspection Bureau, State Administration of Taxation
Ningbo Taxation Bureau
Ningbo Science and technology
Ningbo Finance Bureau
Shengde biological gr202133100527 December 10, 2021 three years 2018
State Administration of Taxation
Ningbo Taxation Bureau
As of the date of this announcement, the company and its wholly-owned subsidiaries Hangzhou Meikang Shengde medical laboratory Co., Ltd., Shenzhen Shengde medical laboratory, Ningbo Shengde medical laboratory and Shengde biology have been recognized as national high-tech enterprises.
Medicalsystem Biotechnology Co.Ltd(300439)
2、 Impact on the operation of the company and its wholly-owned subsidiaries and risk tips
According to the enterprise income tax law of the people’s Republic of China and the relevant provisions of the state on preferential tax policies for high-tech enterprises, the above three wholly-owned subsidiaries will enjoy the relevant preferential policies for high-tech enterprises for three consecutive years after they are recognized as high-tech enterprises, that is, they will pay enterprise income tax at the tax rate of 15%.
The recognition of the above three wholly-owned subsidiaries Shenzhen Shengde medical examination institute, Ningbo Shengde medical examination institute and Shengde biology as high-tech enterprises is not only an affirmation of their technical ability, but also an embodiment of the company’s comprehensive strength, which is conducive to further improving the independent innovation ability and comprehensive competitiveness of the company and its wholly-owned subsidiaries, and will play a positive role in the future development of the company. The above matters will not have a significant impact on the current operating performance of the company. Please pay attention to the investment risks.
3、 Documents for future reference
High tech enterprise certificate.
It is hereby announced.
Medicalsystem Biotechnology Co.Ltd(300439) board of directors January 28, 2022
